Issue link: http://osercommunicationsgroup.uberflip.com/i/709455
An interview with Chris Arington, Chief Executive Officer, Prasco. CCD: Prasco utilizes a unique corporate tag line: Unlimit ® . What does that tag line communicate HOW PRASCO ADDS VALUE TO THE MARKETPLACE An interview with Vimal Kavuru, Chief Executive Officer, Citron Pharma LLC. CDD: What makes Citron unique among other generic companies? Based in Berwyn, Pennsylvania, Amring Pharmaceuticals Inc. is a privately held niche generic pharmaceuti- cal company. The company is part of the global Amring Pharmaceuticals business and is partnered with a well-established An interview with Diane Striegel, M.S., R.D.N., Senior Manager Industry Development. CDD: As people are snack- ing more often, how do your snack foods fit into multiple day parts? As part of the largest generic pharmaceutical divestiture over- seen by the Federal Trade Commission, Mayne Pharma has acquired 42 generic products from Teva Pharmaceutical Industries for RLC Labs in Cave Creek, Arizona, is the maker of Nature-Throid ® and WP Thyroid ® . RLC takes great pride in the fact that it has never had a recall for inconsistent hor- mone content. Its Naturally Desiccated An interview with Sean Clark, Vice President and General Manager, US Self- Medication Business, Galderma. CDD: Why is innovation so important to Galderma? C o ntinued o n P age 8 5 C o ntinued o n P age 8 4 P a n T h e r y x ' s flagship prod- uct, DiaResQ ® , was recently selected by global experts in Reimagining Global Health as one of the 30 leading healthcare innovations with great promise to transform global health by 2030 and to help accelerate C o ntinued o n P age 8 4 C o ntinued o n P age 8 4 C o ntinued o n P age 8 5 C o ntinued o n P age 8 5 C o ntinued o n P age 8 4 C o ntinued o n P age 7 7 CITRON: FOCUSED ON HIGH-VALUE PRODUCTS AMRING PHARMACEUTICALS: PUTTING PEOPLE FIRST SATISFY CUSTOMERS BY ADDRESSING "SNACK MOMENTS" MAYNE PHARMA ACQUIRES 42 GENERIC PRODUCTS FROM TEVA GALDERMA: SCIENCE-BASED SKIN SOLUTIONS RLC LABS: 82 YEARS OF CONSISTENT CONTENT PANTHERYX: INNOVATION IN DIARRHEA RELIEF An interview with Miranda Rochol, Director, Pharmacy Solutions, IMS Health. CDD: What is your goal at NACDS Total Store Expo? IMS HEALTH RAISES AWARENESS OF PHARMACY COMPLIANCE An interview with Mark Deuschle, President, Navajo Inc. CDD: What makes your company unique? MD: The breadth of our offering in In the pharmaceutical industry, temperature management is crucial in maintaining the appropriate tempera- ture of valuable, expen- sive drugs, vaccines and biologics. An interview with Susan Gregory, Chief Executive Officer, NFI. CDD: Tell our readers about your company. SG: NFI is headquartered in Bristol, C o ntinued o n P age 7 7 C o ntinued o n P age 7 5 C o ntinued o n P age 7 7 C o ntinued o n P age 7 5 STAYING ON TOP OF A CHANGING MARKET SMART TEMPS TEMPERATURE MONITORING VIA WEB NFI CONTINUES TO INNOVATE O s e r C o m m u n i ca t i o n s G r o u p B o s t o n M o n d a y, A u g u s t 8 , 2 0 1 6 AN INDEPENDENT PUBLICATION NOT AFFILIATED WITH NACDS